Discontinued — last reported Q3 '21
Rest of World — Net product sales
United Therapeutics Rest of World — Net product sales decreased by 6.3% to $32.60M in Q3 2021 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful international market penetration and growing global demand for the company's therapies, while a decrease may signal competitive pressures, regulatory hurdles, or pricing challenges in foreign markets.
Detailed definition
This metric represents the total revenue generated from product sales in geographic regions outside of the company's pri...
Peer comparison
Most pharmaceutical companies report international revenue as a distinct segment or regional breakdown, allowing for comparison of global commercial reach and exposure to foreign currency fluctuations.
uthr_segment_rest_of_world_net_product_salesHistorical Data
| Q2 '21 | Q3 '21 | |
|---|---|---|
| Value | $34.80M | $32.60M |
| QoQ Change | — | -6.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's rest of world — net product sales?
- United Therapeutics (UTHR) reported rest of world — net product sales of $32.60M in Q3 2021.
- What does rest of world — net product sales mean?
- Total revenue earned from product sales in all countries outside of the company's home market.